NP
IDXX icon

NorthRock Partners’s Idexx Laboratories IDXX Stock Holding History

NorthRock Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$551K Sell
1,046
-1
-0.1% -$561 0.01% 420
2026
Q1 		$588K Buy
1,047
+66
+7% +$42.3K 0.01% 387
2025
Q4 		$664K Sell
981
-1,123
-53% -$765K 0.01% 327
2025
Q3 		$1.34M Buy
2,104
+198
+10% +$120K 0.02% 283
2025
Q2 		$1.02M Buy
1,906
+870
+84% +$416K 0.03% 234
2025
Q1 		$435K Buy
1,036
+36
+4% +$15.6K 0.01% 379
2024
Q4 		$413K Sell
1,000
-898
-47% -$394K 0.01% 397
2024
Q3 		$959K Buy
1,898
+729
+62% +$354K 0.03% 221
2024
Q2 		$570K Buy
1,169
+114
+11% +$57.2K 0.02% 310
2024
Q1 		$570K Buy
1,055
+83
+9% +$45.4K 0.02% 325
2023
Q4 		$540K Buy
972
+446
+85% +$209K 0.02% 304
2023
Q3 		$230K Buy
+526
New +$262K 0.02% 296
2023
Q2 		– Sell
-484
Closed -$242K – 331
2023
Q1 		$242K Sell
484
-163
-25% -$78K 0.03% 269
2022
Q4 		$264K Buy
+647
New +$251K 0.03% 272

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

NorthRock Partners's IDXX Position: Q2 2026 in Review

NorthRock Partners reduced its Idexx Laboratories (IDXX) stake by 0.1% in Q2 2026, selling an estimated $561 and leaving 1,046 shares worth $551K. The position accounts for 0.01% of the portfolio, ranked #420.

NorthRock Partners first reported a position in IDXX in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.34M in Q3 2025. 973 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • NorthRock Partners held 1,046 shares of Idexx Laboratories worth $551K as of Q2 2026.
  • NorthRock Partners sold 1 Idexx Laboratories share in Q2 2026, an estimated $561.
  • Idexx Laboratories made up 0.01% of NorthRock Partners's portfolio in Q2 2026, its #420 holding.
  • NorthRock Partners first reported a position in Idexx Laboratories in Q4 2022 and has held it in 14 quarters since.
  • NorthRock Partners's Idexx Laboratories position peaked at $1.34M in Q3 2025.
  • 973 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on NorthRock Partners's 13F filing for Q2 2026, filed 11 Aug 2026.